Intelligent Bio Solutions
INBS
8 hedge funds and large institutions have $416K invested in Intelligent Bio Solutions in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
2.83% less ownership
Funds ownership: 10.41% → 7.58% (-2.8%)
11% less funds holding
Funds holding: 9 → 8 (-1)
40% less capital invested
Capital invested by funds: $697K → $416K (-$281K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$30K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$14.1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.34K |
| 4 |
Barclays
London,
United Kingdom
|
+$373 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$127K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$20.4K |
| 3 |
CW
Curio Wealth
Annapolis,
Maryland
|
-$669 |
INBS Hedge Fund Activity: Q2 2026 in Review
8 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q2 2026, worth a combined $416K — down 40% from $697K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of INBS and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was Armistice Capital, adding an estimated $30K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $127K sold.
- 8 institutional investors held Intelligent Bio Solutions (INBS) as of Q2 2026, down from 9 in Q1 2026.
- Funds reported $416K of Intelligent Bio Solutions stock for Q2 2026, down 40% quarter-over-quarter.
- 1 fund opened new Intelligent Bio Solutions positions in Q2 2026 and 2 closed out, a net change of -1 holder.
- The largest Intelligent Bio Solutions buyer in Q2 2026 was Armistice Capital, an estimated $30K added.
- The largest Intelligent Bio Solutions seller in Q2 2026 was Alyeska Investment Group, an estimated $127K sold.
Based on aggregated 13F filings for Q2 2026.